Zoetis | ZTS - Ebitda

Aktienkurs
116.87
Täglich Wechseln
0.81 0.70%
Monatlich
0.14%
Jährlich
-23.85%
Q2 Prognose
114.37




Ebitda Veränderung Datum
AbbVie USD 3.52B 828M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
Bayer EUR 1.97B 457M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Charles River Laboratories USD 258.06M 24.83M 2025-12
Coherus Biosciences USD -43.33M 4.7M 2025-09
Dentsply International USD 135M 32M 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Henry Schein USD 291M 4M 2025-12
Idexx Laboratories USD 391.47M 17.97M 2025-09
Illumina USD 332M 12M 2025-09
IQVIA Holdings USD 1.05B 97M 2025-12
J&J USD 7.19B 2.32B 2025-12
Laboratory Of America USD 588.1M 24.1M 2025-12
Merck USD 8.39B 1.97B 2025-09
Neogen USD 48.2M 546K 2025-12
Pacira USD 38.71M 10.65M 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
Phibro Animal Health USD 68.1M 6.2M 2025-12
Quest Diagnostics USD 557M 20M 2026-03
Sanofi EUR 3.31B 3.65B 2026-03
Sanofi EUR 5.66B 3.77B 2025-09
Zoetis USD 1.04B 87M 2025-09